Global Immunohematology Market Growth (Status and Outlook) 2023-2029

Global Immunohematology Market Growth (Status and Outlook) 2023-2029

Immunohematology assists in the screening of blood antigens, Rh factor, plasma, and white blood cell components in the donor blood. It is commonly known as blood banking, which deals with preparation of blood components for transfusion. It aids in reduction of transfusion-related fatalities, such as HIV and thalassemia.

LPI (LP Information)' newest research report, the “Immunohematology Industry Forecast” looks at past sales and reviews total world Immunohematology sales in 2022, providing a comprehensive analysis by region and market sector of projected Immunohematology sales for 2023 through 2029. With Immunohematology sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Immunohematology industry.

This Insight Report provides a comprehensive analysis of the global Immunohematology landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Immunohematology portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Immunohematology market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Immunohematology and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Immunohematology.

The global Immunohematology market size is projected to grow from US$ 1346.3 million in 2022 to US$ 1716 million in 2029; it is expected to grow at a CAGR of 3.5% from 2023 to 2029.

Rising awareness among people in developed as well as developing countries is expected to drive the global immunohematology market in the near future. Increasing health care expenditure and rising worldwide concerns about medical safety are also driving the global immunohematology market. The Asia Pacific region has witnessed gradual adoption of new immunohematology technologies, increasing health care expenditure, and changing dynamics of the in vitro diagnostics industry in the region.

This report presents a comprehensive overview, market shares, and growth opportunities of Immunohematology market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Immunohematology Analyzers and Systems
Immunohematology Reagent

Segmentation by application
Blood-Related Diseases
HIV
Hepatitis

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Bio-Rad Laboratories
Grifols
Immucor
Ortho Clinical Diagnostic
BD
Beckman Coulter
DIAGAST
Hemo bioscience
Institut de Biotechnologies Jacques Boy
MTC INVITRO
Seqirus
Tulip Group

Please note: The report will take approximately 2 business days to prepare and deliver.